Press Releases Medacta Group SA

Equities

MOVE

CH0468525222

Delayed Swiss Exchange Other stock markets 11:31:59 2024-04-30 am EDT			5-day change	1st Jan Change
111.4 ^CHF	-.--%		+1.27%	-11.31%

Mar. 13	Medacta Group SA Proposes Distribution	CI
Mar. 13	Medacta Group SA Provides Earnings Guidance for the Year 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Medacta announces the 10th M.O.R.E. International Symposium in Lugano, Switzerland, celebrating its 25th anniversary worldwide	Apr. 11	EQ
Medacta publishes 2024 Annual General Meeting invitation	Apr. 09	EQ
Medacta : Press Release Ad-Hoc announcement pursuant to Art.53 LR	Mar. 13	PU
Medacta : 2023 Corporate Governance	Mar. 13	PU
Medacta : 2023 Remuneration Report	Mar. 13	PU
Medacta : 2023 Annual Presentation	Mar. 13	PU
Medacta : 2023 Report on Non Financial Matters	Mar. 13	PU
Medacta : 2023 Management Report	Mar. 13	PU
Medacta Group SA: Medacta Group SA reports robust revenue growth of 19.5% at constant currency and adjusted EBITDA1 margin 26.3%, or 27.9% at constant currency in FY 2023	Mar. 13	EQ
Medacta to Feature GMK SpheriKA and Innovative Personalized Solutions at AAOS 2024	Feb. 12	EQ
Medacta Group SA: Medacta Group SA revenues up +19.5% at constant currency1 exceeding the milestone of 500Mln € in FY 2023	Feb. 02	EQ
Medacta’s QUADRA-H hip stem achieves 13A* exemplary quality rating from the British Orthopaedic Data Evaluation Panel (ODEP)	Jan. 08	EQ
A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application	Dec. 14	EQ
Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth	Nov. 29	EQ
Medacta Announces the Launch of GMK SpheriKA, the World's First Knee Implant Optimized for Kinematic Alignment (KA)	23-10-30	EQ
A new study conﬁrms the accuracy of NextAR Shoulder, Medacta’s augmented reality surgical application	23-10-12	EQ
Medacta : 2023 Half-Year Presentation	23-09-22	PU
Medacta Group SA reports strong revenue growth at 21.4% at constant currency and adjusted EBITDA margin at 28.2% in the first semester 2023	23-09-22	EQ
Medacta : 2023 Half-Year Unaudited Top-Line Figures Presentation	23-07-28	PU
Medacta Group SA: 2023 Half-Year Unaudited Top-Line Figures	23-07-28	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Medacta Group SA

Equities

MOVE

CH0468525222

Press Releases

Filters